Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-07-04T05:57:01.467Z Has data issue: false hasContentIssue false
  • English
  • Français

Development & validation of the BSI-9: A brief screening tool for the SAD Triad

Published online by Cambridge University Press:  13 August 2021

C. Macdonald ,
K. Brophy ,
A. Coroiu ,
E. Braehler  and
A. Korner
C. Macdonald*
Affiliation:
Educational And Counselling Psychology, McGill University, Montreal, Canada
K. Brophy
Affiliation:
Educational And Counselling Psychology, McGill University, Montreal, Canada
A. Coroiu
Affiliation:
Social And Behavioural Sciences, Harvard T.H. Chan School of Public Health, Boston, United States of America
E. Braehler
Affiliation:
Psychology, Medical Center of the University of Leipzig, Leipzig, Germany
A. Korner
Affiliation:
Educational And Counselling Psychology, McGill University, Montreal, Canada
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The Brief Symptom Inventory (BSI-53) was originally developed as a shorter alternative to the Symptom Checklist-90R, which captures a breath of psychopathology. Subsequently, the BSI-53 was further streamlined to an 18-item scale assessing psychological distress in terms of somatization (S), anxiety (A), and depression (D) – also known as the “SAD Triad”. The BSI-18 has been shown to have good validity in the German general population.

Objectives

The objective of the present study was to further improve the ease of use of the BSI as a clinical screening tool by developing a reliable and valid 9-item version of the BSI-18.

Methods

A representative sample of the German general population (N=2,516) was surveyed for demographic information and completed a variety of questionnaires, including the BSI-18. Confirmatory factor analyses, item-level statistics, and correlations were used to select three rather heterogeneous items for each subscale and confirm the model fit.

Results

The proposed 3-factor model of the BSI-9, corresponding to the SAD triad, demonstrated a good model fit. The internal consistency (Cronbach’s alpha) was .87 for the total scale, .72 for the somatisation scale, .79 for the depression scale, and .68 for the anxiety scale. Each of the subscales were significantly related to the Patient Health Questionnaire-4 and Hopkins Symptoms Checklist-25 in the hypothesized direction.

Conclusions

The BSI-9 provides researchers and clinicians with a brief, effective, and valid tool to screen for anxiety, depression, and somatization, thus preventing potential overload for research participants and flagging patients who might need further clinical assessment.

Keywords

Scale developmentBrief Symptom InventoryFactor structurePsychological Distress
Type
Abstract
Information
European Psychiatry , Volume 64 , Special Issue S1: Abstracts of the 29th European Congress of Psychiatry , April 2021 , pp. S402
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.